Font:
EM

EMCURE / NSE / Biotechnology & Drugs

Emcure Pharmaceuticals

INR 1,756.820.60 (1.16%) 1D
Last updated: 2026-06-15T19:20:14.422412+00:00
Price Chart

1Y Price Trend

Open1,362.2
High1,830
Low1,228.9
Close1,705.6
Volume2,85,086
Change343.4
Change %25.21%

Key Information

Ticker SymbolEMCURE
Current Price1,756.8
52-Week High1,830
52-Week Low1,228.9
Market Cap33,486.83
Volume2,85,086
ISININE168P01015
Day High1,738.8
Day Low1,681
Open1,732.9

Recommendations

RatingStrong Buy

Target High1,830.35

Target Low1,230

Target Mean1.33

Target Median41.67

Risk Metrics

Overall RiskBalanced risk

Board Risk35.5

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

Emcure FY26 revenue rises 16.6% to ₹9,204 crore, PAT grows 33.1% - scanx.trade7 days ago
Market news

Emcure FY26 revenue rises 16.6% to ₹9,204 crore, PAT grows 33.1% scanx.trade

Emcure Pharmaceuticals Investor Presentation Highlights June 2026 Performance and Future Outlook - InvestyWise7 days ago
Market news

Emcure Pharmaceuticals Investor Presentation Highlights June 2026 Performance and Future Outlook InvestyWise

Emcure Pharmaceuticals Ltd Valuation Shifts Signal Caution Amid Strong Returns - MarketsMojo7 days ago
Market news

Emcure Pharmaceuticals Ltd Valuation Shifts Signal Caution Amid Strong Returns MarketsMojo

Emcure Pharmaceuticals shares rise nearly 4% after Bain Capital divests 2% stake; everything you need to know - Upstox9 days ago
Market news

Emcure Pharmaceuticals shares rise nearly 4% after Bain Capital divests 2% stake; everything you need to know Upstox

BC Investments Sells Rs 612 Crore Stake in Emcure Pharma; Kotak Mahindra Mutual Fund Acquires Shares - Pretax Income Report - newsline.com9 days ago
Market news

BC Investments Sells Rs 612 Crore Stake in Emcure Pharma; Kotak Mahindra Mutual Fund Acquires Shares - Pretax Income Report newsline.com

Stocks to watch, June 10: Afcons Infra, NLC India, Ajanta Pharma, Emcure Pharma, Adani Green, oil-sensitives - Upstox9 days ago
Market news

Stocks to watch, June 10: Afcons Infra, NLC India, Ajanta Pharma, Emcure Pharma, Adani Green, oil-sensitives Upstox

Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta - The Economic Times9 days ago
Market news

Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, Vedanta The Economic Times

PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake - The Economic Times10 days ago
Market news

PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake The Economic Times

FAQ

Stock FAQs

What is the NSE symbol for Emcure Pharmaceuticals?

Emcure Pharmaceuticals trades on NSE with the symbol EMCURE. ShareKeyX uses the stock symbol in the public URL and keeps ISIN only for internal data matching and structured data.

Where can I track Emcure Pharmaceuticals share price and chart?

You can track Emcure Pharmaceuticals share price, OHLC chart, key information, ratios, financials, company information and news on this ShareKeyX market page.

Does ShareKeyX show financial data for Emcure Pharmaceuticals?

Yes. ShareKeyX displays available financial statements for Emcure Pharmaceuticals using the current Supabase company financial payload. Statement values are shown in INR crore.

Does ShareKeyX show historical OHLC data for Emcure Pharmaceuticals?

Yes. ShareKeyX displays available historical OHLC candles for Emcure Pharmaceuticals across supported chart ranges such as 7D, 1M, 3M, 6M and 1Y.

What sector or industry does Emcure Pharmaceuticals belong to?

Emcure Pharmaceuticals is classified under Biotechnology & Drugs in the available company data.

Does ShareKeyX show news for Emcure Pharmaceuticals?

Yes. ShareKeyX shows the latest available stock news for Emcure Pharmaceuticals from the connected stock news source.